Nucleolin on the Cell Surface as a New Molecular Target for Gastric Cancer Treatment
Tatsuro Watanabe(Saga University), Masami Suganuma(Saitama University), Atsushi Takahashi(Juntendo University), Kazuya Hirano(Tokyo University of Pharmacy and Life Sciences), Masatoshi Beppu(Tokyo University of Pharmacy and Life Sciences), Kensei Yamaguchi(Japanese Foundation For Cancer Research), Hirota Fujiki(National Cancer Centre Japan)
Cited by 92
Related Papers
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
|Journal of Cancer Research and Clinical Oncology|1992|807
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
|Proceedings of the National Academy of Sciences|1988|602
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2021|411